These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24953475)

  • 21. Maintenance therapy for multiple myeloma.
    McCarthy PL; Palumbo A
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):839-59. PubMed ID: 25212886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatotoxicity as a rare but serious side effect of thalidomide.
    Levesque E; Bradette M
    Ann Hematol; 2009 Feb; 88(2):183-4. PubMed ID: 18665361
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current treatment strategies with novel agents for multiple myeloma].
    Tokuhira M
    Rinsho Ketsueki; 2011 Aug; 52(8):587-602. PubMed ID: 21897064
    [No Abstract]   [Full Text] [Related]  

  • 24. Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data.
    Offidani M; Corvatta L; Caraffa P; Leoni P; Pautasso C; Larocca A; Palumbo A
    Expert Rev Anticancer Ther; 2014 May; 14(5):499-510. PubMed ID: 24738833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible paraparesis in multiple myeloma with renal failure.
    Terrier B; Joly D; Ghez D; Knebelmann B; Fakhouri F; Hummel A
    Nephrol Dial Transplant; 2006 May; 21(5):1439-40. PubMed ID: 16520348
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent advances in myeloma treatment.
    Schots R
    Transfus Apher Sci; 2011 Apr; 44(2):223-9. PubMed ID: 21349768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients.
    Patriarca F; Sperotto A; Prosdocimo S; Geromin A; Zaja F; Fanin R
    Haematologica; 2003 May; 88(5):597-9. PubMed ID: 12745281
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
    Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
    Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma.
    Gay F; Mina R; Troia R; Bringhen S
    Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1517-27. PubMed ID: 23961770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter.
    Dao K; Chtioui H; Lu Y; Peer CJ; Figg WD; Pruijm M; Buclin T; Kissling S
    Am J Kidney Dis; 2017 Apr; 69(4):553-554. PubMed ID: 28063733
    [No Abstract]   [Full Text] [Related]  

  • 31. Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.
    de la Rubia J; Roig M; Ibáñez A; García I; Vera JA; Aguilar C; del Campo R; González N; Martínez R; Palomera L; Picón I; Rodríguez JN; Sanz MA
    Eur J Haematol; 2010 Oct; 85(4):363-5. PubMed ID: 20662900
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of response to thalidomide-, lenalidomide- or bortezomib- containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation.
    Awan FT; Osman S; Kochuparambil ST; Gibson L; Remick SC; Abraham J; Craig M; Jillella A; Hamadani M
    Bone Marrow Transplant; 2012 Jan; 47(1):146-8. PubMed ID: 21358681
    [No Abstract]   [Full Text] [Related]  

  • 33. Lenalidomide in multiple myeloma.
    Kim Y; Schmidt-Wolf IG
    Expert Rev Anticancer Ther; 2015 May; 15(5):491-7. PubMed ID: 25843431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lenalidomide-associated hepatotoxicity--a case report and literature review.
    Nojkov B; Signori C; Konda A; Fontana RJ
    Anticancer Res; 2012 Sep; 32(9):4117-9. PubMed ID: 22993370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
    Breitkreutz I; Lokhorst HM; Raab MS; Holt Bv; Cremer FW; Herrmann D; Glasmacher A; Schmidt-Wolf IG; Blau IW; Martin H; Salwender H; Haenel A; Sonneveld P; Goldschmidt H
    Leukemia; 2007 Jun; 21(6):1294-9. PubMed ID: 17377586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pomalidomide.
    Engelhardt M; Wäsch R; Reinhardt H; Kleber M
    Recent Results Cancer Res; 2014; 201():359-72. PubMed ID: 24756804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide and hematopoietic-cell transplantation for multiple myeloma.
    Barlogie B; Tricot G; Anaissie E; Shaughnessy J; Rasmussen E; van Rhee F; Fassas A; Zangari M; Hollmig K; Pineda-Roman M; Lee C; Talamo G; Thertulien R; Kiwan E; Krishna S; Fox M; Crowley J
    N Engl J Med; 2006 Mar; 354(10):1021-30. PubMed ID: 16525139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma.
    van de Donk NW; Wittebol S; Minnema MC; Lokhorst HM
    Br J Haematol; 2010 Jan; 148(2):335-7. PubMed ID: 20085583
    [No Abstract]   [Full Text] [Related]  

  • 39. New developments in post-transplant maintenance treatment of multiple myeloma.
    Liu H; McCarthy P
    Semin Oncol; 2013 Oct; 40(5):602-9. PubMed ID: 24135405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lenalidomide in multiple myeloma.
    Richardson PG; Mitsiades C; Hideshima T; Anderson KC
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1165-73. PubMed ID: 16925483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.